SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001171843-24-002033
Filing Date
2024-04-16
Accepted
2024-04-16 17:05:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 F-3/A f3a_041624.htm F-3/A 26751
  Complete submission text file 0001171843-24-002033.txt   27755
Mailing Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2
Business Address 2 BLOOR ST W., 7TH FLOOR TORONTO A6 M4W 3E2 416 648-5555
Medicenna Therapeutics Corp. (Filer) CIK: 0001807983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 0331
Type: F-3/A | Act: 33 | File No.: 333-269868 | Film No.: 24848599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)